MYNARIC DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mynaric AG Investors to Secure Counsel Before Important December 30 Deadline in Securities Class Action – MYNA

Core Viewpoint - Mynaric AG is facing a class action lawsuit due to alleged false and misleading statements regarding production delays and financial guidance, which may have negatively impacted investors during the Class Period [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Mynaric's production delays were caused by lower-than-expected production yields and component supplier shortages for its CONDOR Mk3 product [2]. - These issues are expected to materially affect Mynaric's revenue growth and could lead to an operating loss [2]. - Mynaric is unlikely to meet its previously issued financial guidance for FY 2024, leading to overstated business and financial prospects [2]. Group 2: Class Action Participation - Investors who purchased Mynaric securities between June 20, 2024, and October 7, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][3]. - A lead plaintiff must be appointed by December 30, 2024, to represent other class members in the litigation [6]. - Investors can choose to remain absent from the class or select their own counsel, as no class has been certified yet [5]. Group 3: Rosen Law Firm's Role - The Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered significant amounts for investors, including over $438 million in 2019 [4].